The new Medical Cannabis & Psychedelic Medicines 2026 guide provides the latest legal information on the primary laws and regulations affecting these products, the relevant regulatory authorities, companies’ legal risks, cross-jurisdictional issues, legal elements affecting access to medical cannabis and psychedelic medicines, their use in novel food and wellness products, and decriminalisation and adult use regulation.

The new Dispute Resolution 2026 guide covers more than 40 jurisdictions. The guide provides practitioner insight into the full range of commercial dispute resolution. It compares litigation, arbitration and other forms of ADR, from limitation periods and court procedure to confidentiality, interim and final relief, damages, funding and costs. It covers class actions, disclosure and privilege, enforcement of judgments and awards, as well as emerging AI issues.

The Healthcare M&A 2026 guide provides the latest legal information on market trends; establishing healthcare start-ups, including early-stage financing and venture capital; IPOs and private sales; spin-offs; acquisition of listed companies, including stakebuilding, documentation, squeeze-out mechanisms, certain funds requirements and deal protection measures; regulatory requirements, including antitrust, foreign investment review and data privacy concerns; disclosure obligations; and duties of directors.

The Artificial Intelligence 2026 guide features more than 30 jurisdictions. The guide provides the latest legal information on the rapidly evolving AI landscape, covering the commercial use of AI across key industries, AI-specific legislation and regulation, government and regulatory oversight, generative AI, agentic AI systems and autonomous decision-making, liability, procurement and supply chain accountability, employment, IP, data protection, antitrust, cybersecurity, ESG, and AI governance and compliance.